|
1
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cheng L, Davison DD, Adams J, LopezBeltran
A, Wang L, Montironi R and Zhang S: Biomarkers in bladder cancer:
Translational and clinical implications. Crit Rev Oncol Hematol.
89:73–111. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Morgan TM, Keegan KA and Clark PE: Bladder
cancer. Curr Opin Oncol. 23:275–282. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhao Q, Wang H, Yang M, Yang D, Zuo Y and
Wang J: Expression of a tumor-associated gene, LASS2, in the human
bladder carcinoma cell lines BIU-87, T24, EJ and EJ-M3. Exp Ther
Med. 5:942–946. 2013.PubMed/NCBI
|
|
5
|
Pan H, Qin WX, Huo KK, Wan DF, Yu Y, Xu
ZG, Hu QD, Gu KT, Zhou XM, Jiang HQ, et al: Cloning, mapping and
characterization of a human homologue of the yeast longevity
assurance gene LAG1. Genomics. 77:58–64. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yu W, Wang L, Wang Y, Xu X, Zou P, Gong M,
Zheng J, You J, Wang H, Mei F and Pei F: A novel tumor metastasis
suppressor gene LASS2/TMSG1 interacts with vacuolar ATPase through
its homeodomain. J Cell Biochem. 114:570–583. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xu XY, You JF, Pei F and Zhang B:
Silencing of tumor metastasis suppressor gene 1 promotes invasion
of prostate cancer cell in vitro and its molecular mechanisms.
Beijing Da Xue Xue Bao. 43:814–819. 2011.(In Chinese). PubMed/NCBI
|
|
8
|
Xu X, You J and Pei F: Silencing of a
novel tumor metastasis suppressor gene LASS2/TMSG1 promotes
invasion of prostate cancer cell in vitro through increase of
vacuolar ATPase activity. J Cell Biochem. 113:2356–2363. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tang N, Jin J, Deng Y, Ke RH, Shen QJ, Fan
SH and Qin WX: LASS2 interacts with V-ATPase and inhibits cell
growth of hepatocellular carcinoma. Sheng Li Xue Bao. 62:196–202.
2010.(In Chinese). PubMed/NCBI
|
|
10
|
Fan S, Niu Y, Tan N, Wu Z, Wang Y, You H,
Ke R, Song J, Shen Q, Wang W, et al: LASS2 enhances
chemosensitivity of breast cancer by counteracting acidic tumor
microenvironment through inhibiting activity of V-ATPase proton
pump. Oncogene. 32:1682–1690. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Schiffmann S, Sandner J, Birod K, Wobst I,
Angioni C, Ruckhäberle E, Kaufmann M, Ackermann H, Lötsch J,
Schmidt H, et al: Ceramide synthases and ceramide levels are
increased in breast cancer tissue. Carcinogenesis. 30:745–752.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hartmann D, Lucks J, Fuchs S, Schiffmann
S, Schreiber Y, Ferreirós N, Merkens J, Marschalek R, Geisslinger G
and Grösch S: Long chain ceramides and very long chain ceramides
have opposite effects on human breast and colon cancer cell growth.
Int J Biochem Cell Biol. 44:620–628. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Egeblad M and Werb Z: New functions for
the matrix metalloproteinases in cancer progression. Nat Rev
Cancer. 2:161–174. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang H, Wang J, Zuo Y, Ding M, Yan R, Yang
D and Ke C: Expression and prognostic significance of a new tumor
metastasis suppressor gene LASS2 in human bladder carcinoma. Med
Oncol. 29:1921–1927. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu H, Tan Q, Geddie WR, Jewett MA,
Phillips N, Ke D, Simmons CA and Sun Y: Biophysical
characterization of bladder cancer cells with different metastatic
potential. Cell Biochem Biophys. 68:241–246. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xu X, Liu B, Zou P, Zhang Y, You J and Pei
F: Silencing of LASS2/TMSG1 enhances invasion and metastasis
capacity of prostate cancer cell. J Cell Biochem. 115:731–743.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2 (−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lu X, Qin W, Li J, Tan N, Pan D, Zhang H,
Xie L, Yao G, Shu H, Yao M, et al: The growth and metastasis of
human hepatocellular carcinoma xenografts are inhibited by small
interfering RNA targeting to the subunit ATP6L of proton pump.
Cancer Res. 65:6843–6849. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Seiler R, Thalmann GN and Fleischmann A:
MMP-2 and MMP-9 in lymph-node-positive bladder cancer. J Clin
Pathol. 64:1078–1082. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mei F, You J, Liu B, Zhang M, Liu J, Zhang
B and Pei F: LASS2/TMSG1 inhibits growth and invasion of breast
cancer cell in vitro through regulation of vacuolar ATPase
activity. Tumour Biol. 36:2831–2844. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Undem C, Rios EJ, Maylor J and Shimoda LA:
Endothelin-1 augments Na(+)/H(+) exchange
activity in murine pulmonary arterial smooth muscle cells via Rho
kinase. PloS One. 7:e463032012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sasazawa Y, Futamura Y, Tashiro E and
Imoto M: Vacuolar H+-ATPase inhibitors overcome
Bcl-xL-mediated chemoresistance through restoration of a
caspase-independent apoptotic pathway. Cancer Sci. 100:1460–1467.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Basu A and Haldar S: The relationship
between BcI2, Bax and p53: Consequences for cell cycle progression
and cell death. Molecular Hum Reprod. 4:1099–1109. 1998. View Article : Google Scholar
|
|
24
|
Mizutani Y, Kihara A and Igarashi Y:
Mammalian Lass6 and its related family members regulate synthesis
of specific ceramides. Biochem J. 390:263–271. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ponnusamy S, MeyersNeedham M, Senkal CE,
Saddoughi SA, Sentelle D, Selvam SP, Salas A and Ogretmen B:
Sphingolipids and cancer: Ceramide and sphingosine-1-phosphate in
the regulation of cell death and drug resistance. Future Oncol.
6:1603–1624. 2010. View Article : Google Scholar : PubMed/NCBI
|
